Publications in collaboration with researchers from Hospital de Sabadell (3)

2018

  1. Efficacy and safety of vandetanib for patients with advanced and progressive medullary thyroid cancer (MTC) as systemic treatment beyond first-line therapy

    Annals of oncology : official journal of the European Society for Medical Oncology, Vol. 29, pp. viii476